MAXONA Pharmaceuticals: Latest News, Top Stories & Analysis

MALVERN, PA — Maxona Pharmaceuticals has announced the issuance of Patent No. 12,226,421 by the United States Patent and Trademark Office (USPTO) for MAX-001, the company’s breakthrough non-opioid, non-NSAID oral therapy …

Research

MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy

February 12, 2025February 11, 2025 - by Timothy Alexander

MALVERN, PA — MAXONA Pharmaceuticals has officially emerged from stealth mode, announcing the successful completion of its U.S. Phase 1 clinical trials for MAX-001, a groundbreaking non-opioid, non-NSAID oral therapy designed …